Suga says Japan has secured enough COVID-19 "antibody cocktails"

Kyodo -- Aug 16
Prime Minister Yoshihide Suga said Japan has secured enough "antibody cocktails" to prevent COVID-19 patients in the country from developing severe symptoms, as he visited a Tokyo hotel on Monday that is conducting the treatment amid an increasing strain on hospital beds.

Patients with mild symptoms are staying at the Shinagawa Prince Hotel in Minato Ward and undergoing the treatment, which according to overseas clinical trials lowers the risk of hospitalization or death by about 70 percent.

"We want to prevent at any cost patients from developing serious symptoms as we arrange for hotels like this one to serve as medical facilities for administering the medicine," said Suga.

Tokyo Gov. Yuriko Koike who accompanied Suga and health minister Norihisa Tamura during the visit said she hopes the use of such hotels will spread not just within Tokyo but also in other areas.

Suga has announced his plan to create hubs to conduct the treatment soon, hoping to reduce the number of patients with serious symptoms that has been on the rise with the spread of the highly contagious Delta variant of the novel coronavirus in Japan.

The antibody cocktail treatment uses casirivimab and imdevimab developed by U.S. firm Regeneron Pharmaceuticals Inc. and Swiss health care company F. Hoffmann-La Roche Ltd. and is administered intravenously. It was famously used to treat former U.S. President Donald Trump for COVID-19.

- Kyodo

新型コロナの治療薬を投与できる拠点を全国に整備する方針です。  菅総理大臣:「こうしたホテルを(治療薬を)投与できる臨時の医療施設として全国の拠点に整備するなかで、そうした患者の重症化というものを何としても防いでいきたい」  菅総理が視察した宿泊療養施設では、重症化リスクを防ぐとされる「抗体カクテル療法」が実施されています。  視察に同行した小池知事は「大きな武器になり得る」として、この治療薬に期待感を示しました。 - ANNnewsCH